跳至主要内容
临床试验/NCT04396015
NCT04396015已完成不适用

Evaluating Cognitive and Functional Impairment in Alzheimer's Dementia With a Ketogenic Diet.

University of Alberta0 个研究点目标入组 20 人开始时间: 2016年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
主要终点
Behavior

研究概览

简要总结

The present study is being done in a scientifically rigorous manner, using readily available MCT oil (refined from coconut oil) versus a placebo oil to assess any cognitive and functional benefits for AD patients.

详细描述

The proposed study, is a randomized placebo controlled cross-over study for 6 months, with an open label extension for another 6 months designed to test the benefits and safety of MCT oil in patients with established AD. It will be the first study on MCT oil ever done with this design, and for this duration in AD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

Double blind placebo controlled

入排标准

年龄范围
50 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients >49years with a clinical diagnosis of AD
  • Mini Mental Status Examination (MMSE) score 10-29/30
  • on stable dose of medications for 3 months (AChEI, memantine and antidepressants allowed)
  • able to speak English
  • patient or designate able to sign informed consent
  • stable chronic medical conditions (Heart disease, thyroid disease)
  • reliable caregiver

排除标准

  • age <50 years
  • medically unstable
  • unable to swallow liquids
  • diagnosis of diabetes mellitus
  • residence in a nursing/long term care home
  • allergy to coconut
  • allergy to olive oil

结局指标

主要结局

Behavior

时间窗: 15 months

Neuropsychiatric Inventory (NPI) 0-96 Higher score with more behaviour problems

cognition

时间窗: 15 months

Cognigram (Cogstate) 0-200. Higher score with higher cognitive function

Cognition

时间窗: 15 months

Montreal Cognitive Assessment (MoCA) 0-30. Higher score with higher cognition

Function

时间窗: 15 months

Katz Activities of Daily Living Scale 0-6 Higher score with poorer ADL function

次要结局

  • maximum tolerated daily dose (ml) of placebo (olive) oil(4 months)
  • Serum cholesterol mmol/l(15 months)
  • maximum tolerated daily dose (ml) of MCT oil(11 months)
  • Serum Low density lipoprotein (LDL) mmol/l(15 months)
  • Dual Energy Absorptiometry (DXA) Body fat(15 months)
  • Incidence of treatment-emergent Adverse events(15 months)
  • Serum Triglyceride mmol/l(15 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Angela Juby

Professor of Medicine

University of Alberta

相似试验